About FDA

Index

Filter

Results

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.

Number of results: 34

	Item	Program	Office	Program Status	Type	Download
1	Number of OCET-coordinated meetings regarding CT and ET issues with Centers in the month	OCS	Office of Counterterrorism and Emerging Threats	Completed	Program Measures
2	Number of external meetings (hosted by CDC, NIH, industry, and sponsors) attended by OCET to communicate agency policy on CT and ET in the month	OCS	Office of Counterterrorism and Emerging Threats	Completed	Program Measures
3	Number of meetings to discuss Pre-Emergency Use Authorization (EUA) development in the month	OCS	Office of Counterterrorism and Emerging Threats	Completed	Program Measures
4	Number of documents reviewed for CT and ET policy development in the month	OCS	Office of Counterterrorism and Emerging Threats	Completed	Program Measures
5	Total number of meeting requests received through MCM.gov in the month	OCS	Office of Counterterrorism and Emerging Threats	Completed	Program Measures
6	Number of meetings FDA attends with sponsors who requested a meeting through MCM.gov in the month	OCS	Office of Counterterrorism and Emerging Threats	Completed	Program Measures
7	Implement MCM Initiative (MCMi)	OCS	Office of Counterterrorism and Emerging Threats	Completed	Key Projects
8	Strategic Science and Innovation Plan	OCS	Office of the Chief Scientist	Completed	Key Projects
9	Tuberculosis Initiative	OCS	Office of Regulatory Science and Innovation	Completed	Key Projects
10	Tuberculosis Frozen Trial Repository	OCS	Office of Regulatory Science and Innovation	Active	Key Projects
11	Neglected/Tropical Disease Initiative	OCS	Office of Regulatory Science and Innovation	Completed	Key Projects
12	Modernize Toxicology Testing	OCS	Office of Regulatory Science and Innovation	Completed	Key Projects
13	Improving the Efficiency of Clinical Trials	OCS	Office of Regulatory Science and Innovation	Completed	Key Projects
14	Health Resources and Services Administration (HRSA) Patient Safety and Clinical Pharmacy Services Collaborative	OCS	Office of Women's Health	Completed	Key Projects
15	Video Novella	OCS	Office of Women's Health	Completed	Key Projects
16	Number of OWH staff attending venues and partner activities where women’s information is provided in the month	OCS	Office of Women's Health	Active	Program Measures
17	Total number of electronic OWH distributions in English and other foreign languages in the quarter	OCS	Office of Women's Health	Active	Program Measures
18	Total number of physical OWH distributions in English and other foreign languages in the quarter	OCS	Office of Women's Health	Active	Program Measures
19	Total number of OWH partner distributions in the quarter	OCS	Office of Women's Health	Active	Program Measures
20	Cumulative number of subscribers to OWH email lists and social media outlets at the end of the month	OCS	Office of Women's Health	Active	Program Measures
21	Cumulative number of abstracts, posters, presentations or publications by OWH staff accepted in the month	OCS	Office of Women's Health	Active	Program Measures
22	Commissioner’s Fellowship Program	OCS	Office of Scientific Professional Development	Active	Key Projects
23	Modernizing Toxicology	OCS	Office of the Chief Scientist	Active	Key Projects
24	Centers of Excellence in Regulatory Science and Innovation (CERSI)	OCS	Office of Regulatory Science and Innovation	Active	Key Projects
25	Broad Agency Announcement (BAA)	OCS	Office of Regulatory Science and Innovation	Active	Key Projects
26	FDA Nanotechnology Regulatory Science Program	OCS	Office of Regulatory Science and Innovation	Active	Key Projects
27	Number of Departmental meetings in the month related to HHS Health Disparities Plan Implementation	OCS	Office of Minority Health	Active	Program Measures
28	Number of HHS and FDA working groups impacting health literacy led or participated in during the month	OCS	Office of Minority Health	Active	Program Measures
29	Number of OMH Steering committee meetings and outreach activities led by OMH staff in the month	OCS	Office of Minority Health	Active	Program Measures
30	Number of Departmental meetings in the month related to ACA implementation	ACA	Office of Minority Health	Completed	Program Measures
31	Cumulative number of visits to new FDA minority health webpage in the month	ACA	Office of Minority Health	Active	Program Measures
32	Number of external FDA stakeholder meetings in the month	ACA	Office of Minority Health	Active	Program Measures
33	Strengthen FDA capacity to address minority health and health disparities across the Agency	ACA	Office of Minority Health	Active	Key Projects
34	Strengthen Regulatory Science/Health Disparities Research Initiatives	ACA	Office of Minority Health	Active	Key Projects